Chiari malformation
Chiari malformation
Chiari malformation
Chiari malformation
Chiari malformation (CM) encompasses a spectrum of congenital or acquired hindbrain anomalies characterized by the downward displacement of cerebellar and, variably, brainstem structures through the foramen magnum, leading to disrupted cerebrospinal fluid (CSF) dynamics and potential neural compression.
Classification and Clinical Entities
The most recognized classification comprises four types:
Type I: Involves the herniation of cerebellar tonsils ≥5 mm below the foramen magnum, with brainstem structures typically spared. CM-I often presents in adolescence or adulthood. Patients may be asymptomatic or exhibit occipital headaches, neck pain, dizziness, and symptoms of brainstem or spinal cord dysfunction. Many cases are associated with syringomyelia—development of a fluid-filled syrinx within the spinal cord[1][2][3][4]. Accumulating evidence also recognizes a "Chiari 1.5" entity, marked by both cerebellar tonsillar and brainstem herniation. Its clinical and radiological overlap with CM-I complicates management and suggests a possibly worse prognosis, particularly in cases with syringomyelia, some of which may require repeat surgical intervention[5].
Type II (Arnold-Chiari Malformation): Features more profound brainstem and cerebellar displacement along with a small posterior fossa and associated myelomeningocele; typically presents neonatally with more severe neurological compromise.
Types III and IV: These rarer forms show further degrees of CNS and cranial dysplasia, including encephalocele (type III) or cerebellar aplasia/hypoplasia (type IV). These forms are most often fatal or yield profound neurological impairment.
An additional association exists between CM and craniosynostosis, particularly lambdoid and multisuture synostosis. In such patients, CM and even associated syringomyelia may resolve following cranial vault expansion. However, novel or progressive CM may emerge after initial synostosis repair, necessitating ongoing surveillance[6].
Pathogenesis and Etiology
CM-I’s origins appear multifactorial. The "small posterior fossa" hypothesis posits a mismatch between the volume of hindbrain neural tissue and the bony compartment, promoting herniation[3]. This restriction may be congenital due to aberrant skull base or cranial development (including genetic syndromes and craniosynostosis), or acquired, as in the case of CSF leakage or overdrainage of ventricular shunts[6][7]. CSF hydrodynamics are central: herniated hindbrain tissue increases resistance to CSF flow at the craniospinal junction, leading to abnormal pressure gradients and impaired pulsatile CSF exchange[2][8]. These altered dynamics likely underpin pathogenesis both of syringomyelia and the neurological sequelae seen in CM-I[2][4][8][9].
Genetic advances continue to elucidate specific molecular drivers in select patients, such as EPAS1 gain-of-function mutations resulting in aberrant skull base ossification and associated CM-I within defined syndromic contexts[7].
Diagnosis
MRI is the gold standard for evaluation, providing essential details on the extent of tonsillar herniation and associated lesions (e.g., syrinx, hydrocephalus)[2][3]. Cine phase-contrast MRI offers dynamic assessment of CSF flow and is valuable in both diagnosis and surgical planning[2]. CT complements MRI for bony anatomy—of relevance in craniosynostosis or assessing post-surgical change[6].
Symptoms and Clinical Course
Classic symptoms in CM-I include suboccipital headaches—worsened by Valsalva maneuvers—neck pain, ataxia, dysphagia, sensory disturbances, and evidence of lower cranial nerve or cerebellar involvement. Syringomyelia can produce dissociated sensory loss, weakness, and scoliosis[1][2][3][4]. However, symptomatology is highly variable and some patients remain asymptomatic throughout life. No singular symptom is pathognomonic for CM-I or for distinguishing its "1.5" variant; instead, imaging-guided stratification remains key[5].
Management
Asymptomatic patients may be monitored with serial clinical and radiological assessment[1][3].
Symptomatic patients—particularly those with significant headaches, brainstem compromise, or progressive syringomyelia—are candidates for surgery. The mainstay of treatment is posterior fossa decompression (PFD), usually involving suboccipital craniectomy, possible C1 laminectomy, and duraplasty to mitigate crowding and normalize CSF flow[1][2][3][9]. Intraoperative exploration may reveal obstructive pathologies (e.g., arachnoid veils at the foramen of Magendie), especially in cases with syringomyelia, and fenestration may be required to re-establish CSF communication[9].
Functional neuroimaging such as cine-MRI is increasingly incorporated pre- and post-operatively to evaluate CSF flow restoration, which correlates with symptom improvement[2][8]. Notably, in patients with concurrent craniosynostosis, craniofacial expansion alone may suffice for CM and syrinx resolution in select cases, but vigilance for postoperative de novo CM is warranted[6].
Prognosis and Outcomes
PFD yields robust and durable symptom relief in the majority of CM-I cases, particularly for headache and brainstem deficits[1][2][3]. Syringomyelia symptoms tend to improve or stabilize—an outcome considered successful due to the often progressive course in untreated disease[1]. However, some patients (such as those with "Chiari 1.5" or persistent syringomyelia) may need revision surgery[1][5].
Contemporary Research Directions
Ongoing research efforts focus on:
Chiari malformation thus represents a dynamic and heterogeneous neurosurgical disorder at the intersection of developmental neuroanatomy, CSF physiology, genetics, and cranial biomechanics. Advances in multimodal imaging, surgical technique, and molecular pathogenesis continue to refine both diagnosis and management for affected individuals[2][4][7][8].
BINDAL, A. K.; DUNSKER, S.; TEW, J. Chiari i malformation: Classification and management. Neurosurgery, 1995. https://doi.org/10.1097/00006123-199512000-00005.
ELLENBOGEN, R., et al. Toward a rational treatment of chiari i malformation and syringomyelia. Neurosurgical focus, 2000. https://doi.org/10.3171/foc.2000.8.3.6.
ALDEN, T.; OJEMANN, J.; PARK, T. Surgical treatment of chiari i malformation: Indications and approaches. Neurosurgical focus, 2001. https://doi.org/10.3171/foc.2001.11.1.3.
SEKULA, R., et al. The pathogenesis of chiari i malformation and syringomyelia. Neurological Research, 2011. https://doi.org/10.1179/016164111x12962202723724.
TUBBS, R., et al. A critical analysis of the chiari 1.5 malformation. Journal of neurosurgery, 2004. https://doi.org/10.3171/ped.2004.101.2.0179.
STRAHLE, Jennifer M., et al. Chiari malformation associated with craniosynostosis. Neurosurgical focus, 2011. https://doi.org/10.3171/2011.6.focus11107.
ROSENBLUM, Jared S, et al. Chiari malformation type 1 in epas1-associated syndrome. International Journal of Molecular Sciences, 2019. https://doi.org/10.3390/ijms20112819.
SHAFFER, Nicholas; MARTIN, B.; LOTH, F. Cerebrospinal fluid hydrodynamics in type i chari malformation. Neurological research, 2011. https://doi.org/10.1179/016164111x12962202723805.
TUBBS, R., et al. Arachnoid veils and the chiari i malformation. Journal of neurosurgery, 2004. https://doi.org/10.3171/ped.2004.100.5.0465.
Occupational therapy management for Huntington disease
Occupational therapy management for Huntington disease
Occupational therapy (OT) management for Huntington disease (HD) is a critical component of multidisciplinary care aimed at sustaining functional ability, enhancing quality of life, and supporting both patients and caregivers throughout all stages of this progressive neurodegenerative disorder. HD presents with motor disturbances (notably chorea and dystonia), cognitive decline, and various psychiatric symptoms, all of which progressively undermine independence and participation in daily activities [1]. As highlighted in recent burden of illness data, the direct and indirect costs and care needs of HD rise with disease progression, underscoring the importance of interventions that delay functional loss and provide meaningful support to families [2].
Stage-Specific Occupational Therapy Interventions
Occupational therapy for HD is most effective when individualized and responsive to stage-specific challenges:
Early Stage During the early (preclinical or mildly symptomatic) stage, the key focuses are sustaining engagement in work, leisure, and self-care, and preemptively addressing emerging cognitive and emotional symptoms. OT interventions may include workplace and home ergonomic assessments, compensatory cognitive strategies (e.g., calendars, reminders), and energy conservation techniques. Patients and families are also counseled regarding disease understanding and proactive planning for progressive loss of function [1]. Early intervention provides a baseline for future skills and ensures patient and caregiver empowerment as needs evolve [2].
Middle Stage In the middle stage, as chorea, balance, and cognitive impairments intensify, OTs work to maximize independence in activities of daily living (ADLs), prioritize safety, and minimize risk. Interventions typically involve task simplification, adaptive equipment (e.g., weighted utensils, non-slip mats), home modifications (grab bars, removal of trip hazards), and structured cognitive cueing routines. Training caregivers in safe patient handling, feeding assistance, and behavioral strategies becomes paramount, as caregiver burden and economic strain sharply increase [2].
Late Stage Late-stage HD is characterized by profound immobility, cognitive decline, and full dependence. OT focuses on comfort, prevention of contractures and pressure injuries through positioning and passive range-of-motion (ROM) exercises (in collaboration with physical therapy), and adaptive feeding strategies, especially in the presence of dysphagia [1]. Sensory stimulation—such as music or aromatherapy—may be used to maintain engagement and dignity. Caregiver support is intensified to reduce burnout and prepare for end-of-life care, consistent with best-practice multidisciplinary approaches [2].
Key Cross-Cutting Themes in OT for HD
Evidence Base and Recommendations
Although the field would benefit from more robust, high-quality trials specifically in HD, consensus and emerging research endorse patient-centered and function-oriented OT interventions. Guidelines advocate for early involvement of OT services, regular reassessment, and adaptive goal-setting involving the patient and caregivers. These approaches are supported by cost, burden of illness, and patient quality of life outcome studies, which collectively illustrate the potential for OT-led strategies to delay institutionalization, reduce downstream costs, and enhance dignity and comfort [1][2]. There is also substantiation from related neurodegenerative disorders (e.g., Parkinson’s disease) that tailored, meaningful, and multidisciplinary OT interventions optimize performance in daily living and participation in social roles [3][4], suggesting applicability to idiopathic disorders with similar functional trajectories such as HD.
Conclusion
Occupational therapy is indispensable in the comprehensive management of Huntington disease, offering stage-based interventions that address evolving cognitive, physical, and psychosocial deficits. Through skilled assessment and ongoing adaptation, OTs promote autonomy, safety, and quality of life for individuals with HD and their families, while helping to mitigate the substantial socioeconomic burden inherent to this disorder [1][2].
HARPER, Benham. Huntington disease. Journal of the Royal Society of Medicine, 2005. https://doi.org/10.1177/014107680509801216.
RODRIGUEZ-SANTANA, I., et al. Economic burden of huntington disease in europe and the USA: Results from the huntington's disease burden of illness study. European Journal of Neurology, 2022. https://doi.org/10.1111/ene.15645.
STURKENBOOM, I., et al. Economic evaluation of occupational therapy in parkinson's disease: A randomized controlled trial. Movement Disorders, 2015. https://doi.org/10.1002/mds.26217.
WELSBY, E.; BERRIGAN, Sonja; LAVER, K. Effectiveness of occupational therapy intervention for people with parkinson's disease: Systematic review. Australian occupational therapy journal, 2019. https://doi.org/10.1111/1440-1630.12615.
Management of incoordination
Management of incoordination
Management of incoordination—most commonly manifesting as ataxia or impaired coordination of movement—is best understood as a multidimensional process that addresses motor, functional, cognitive, and psychosocial aspects. Current research highlights that while the underlying etiologies can vary (including cerebellar degeneration, Parkinson’s disease, and Huntington disease), effective management consistently requires tailored, intensive rehabilitation with multidisciplinary input, compensatory strategies, technology integration, and ongoing adaptation to disease progression.
Comprehensive Assessment and Individualized Goal Setting
The foundation of effective management is a thorough, standardized evaluation of the type and severity of incoordination and its impact on daily function. Instrumental tests such as the 9-Hole Peg Test, Berg Balance Scale, and the BRAIN online incoordination assessment provide reliable quantification of upper and lower extremity deficits and can be utilized both clinically and in the home setting to monitor progress and guide therapy adaptation [1].
Rehabilitation Interventions
Occupational and Physical Therapy
There is compelling evidence that multidisciplinary rehabilitation—particularly structured occupational therapy and physical therapy—results in meaningful improvements in motor coordination, balance, ataxia, and overall functional independence for individuals with neurodegenerative and genetic ataxias [2]. Occupational therapy interventions are most effective when individualized and goal-oriented, focusing on direct practice of problematic ADLs (e.g. feeding, dressing) and incorporating compensatory aids (e.g. weighted utensils, adapted dressing tools) that mitigate the impact of incoordination in daily life [3]. Upper limb therapy programs can offer short-term improvements in coordination, though the durability of benefit appears to necessitate ongoing or intermittent intervention [3]. Physical therapy complements this with targeted balance, gait, and core stability exercises to address postural instability and prevent falls [2]. Notably, specialized exercises such as coordination and balance training, treadmill walking, and cycling regimes have all demonstrated significant improvement in functional outcomes and motor coordination in clinical trials and cohort studies [2].
Adjunctive and Technology-Assisted Therapies
Emerging modalities such as biofeedback, virtual reality platforms, and robotic-assisted training provide intensive, repetitive practice and real-time feedback—critical components for neuroplasticity and skill acquisition. Systematic reviews suggest that technology-assisted balance training, including game-console based rehabilitation programs (e.g. Xbox-based exercises for Parkinson's patients), produce superior outcomes in incoordination and postural control measures compared to standard rehabilitation alone [2][4]. Such interventions are feasible for home-based or outpatient use, improving access and long-term engagement.
Assistive Devices and Environmental Modification
The use of adaptive devices (built-up handles, scoop dishes, non-slip mats) and environmental modifications (grab bars, strategic furniture placement) are central to reducing secondary injury, promoting independence, and conserving energy [3]. These strategies are particularly important for progressive conditions where curative treatments are unavailable, allowing patients to maintain participation in meaningful activities throughout disease progression [5].
Medical and Pharmacological Management
While rehabilitative approaches form the core of management, addressing reversible causes (e.g. vitamin deficiencies, metabolic derangements) is fundamental where applicable [6]. In experimental models, select pharmacological agents (e.g. PPAR-α agonists such as clofibrate) show potential for neuroprotection and reduction of motor incoordination due to their anti-inflammatory and anti-oxidant properties, though translation to clinical practice for chronic or degenerative human pathologies requires further investigation [6]. In some cases, symptomatic medications such as those targeting tremor or dystonia may offer incremental benefit as part of an individualized plan.
Long-Term Management and Prognosis
Most etiologies of incoordination—whether hereditary (as in spinocerebellar ataxias) or degenerative (as in Parkinson's or Huntington disease)—exhibit progressive trajectories [7][8][9]. Systematic reviews consistently highlight that rehabilitation improves function, ataxia, and balance in the short term, but that long-term benefit requires sustained or repeated intervention due to ongoing neurodegeneration [2]. Therefore, management must be adaptive, involving regular re-assessment, early integration of supportive technology, and ongoing patient/caregiver education.
Cognitive, Psychiatric, and Social Considerations
Patients with incoordination—particularly those with cerebellar or basal ganglia involvement—often experience cognitive and neuropsychiatric deficits, which can exacerbate motor dysfunction and impede rehabilitation [5][7]. Integration of neuropsychological assessment, behavioral strategies, and psychosocial support is essential to maximize engagement, promote self-efficacy, and preserve quality of life [5].
Summary
In sum, robust evidence supports that the management of incoordination is most effective when it is multidisciplinary, functionally targeted, and adapted to evolving patient-specific needs. High-intensity, goal-oriented rehabilitation—including both traditional and technology-based approaches—yields significant improvements in coordination, mobility, and independence, though sustained benefit typically relies on ongoing engagement [2][3][4]. Assistive devices, environmental adaptation, pharmacological symptom management, and attention to psychosocial determinants further enhance outcomes and quality of life for affected individuals across a spectrum of neurological disorders.
NOYCE, A., et al. Bradykinesia-akinesia incoordination test: Validating an online keyboard test of upper limb function. PLoS ONE, 2013. https://doi.org/10.1371/journal.pone.0096260.
MILNE, Sarah C., et al. Rehabilitation for individuals with genetic degenerative ataxia: A systematic review. Neurorehabilitation and Neural Repair, 2017. https://doi.org/10.1177/1545968317712469.
WELSBY, E.; BERRIGAN, Sonja; LAVER, K. Effectiveness of occupational therapy intervention for people with parkinson's disease: Systematic review. Australian occupational therapy journal, 2019. https://doi.org/10.1111/1440-1630.12615.
ÖZGÖNENEL, L., et al. Use of game console for rehabilitation of parkinson's disease. Balkan medical journal, 2016. https://doi.org/10.5152/balkanmedj.2016.16842.
SCHMAHMANN, J. Disorders of the cerebellum: Ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. The Journal of neuropsychiatry and clinical neurosciences, 2004. https://doi.org/10.1176/jnp.16.3.367.
OYAGBEMI, A., et al. Clofibrate, a PPAR‐α agonist, abrogates sodium fluoride‐induced neuroinflammation, oxidative stress, and motor incoordination via modulation of gfap/iba‐1/anti‐calbindin signaling pathways. Environmental Toxicology, 2019. https://doi.org/10.1002/tox.22861.
HARPER, Benham. Huntington disease. Journal of the Royal Society of Medicine, 2005. https://doi.org/10.1177/014107680509801216.
FALCON, M. I., et al. Early cerebellar network shifting in spinocerebellar ataxia type 6. Cerebral cortex, 2016. https://doi.org/10.1093/cercor/bhv154.
YU, Guo-Yun, et al. Spinocerebellar ataxia type 26 maps to chromosome 19p13.3 adjacent to SCA6. Annals of Neurology, 2005. https://doi.org/10.1002/ana.20371.
Head injury patient in vegetative state
Head injury patient in vegetative state
A vegetative state (VS) after head injury, also known as unresponsive wakefulness syndrome, remains one of the most challenging outcomes in neurocritical care, carrying profound diagnostic, prognostic, ethical, and management implications.
Definition and Diagnostic Nuances
A patient in the vegetative state demonstrates physiological wakefulness (sleep–wake cycles, eye opening) without behavioral evidence of awareness or purposeful response to external stimuli. This syndrome arises principally after severe traumatic brain injury (TBI), anoxic-ischemic insult, or other diffuse cerebral insults, with loss of cortical integrative functioning but relative sparing of brainstem autonomic control. The classic diagnostic criteria distinguish VS from coma (absence of wakefulness), minimally conscious state (MCS; intermittent and reproducible evidence of awareness), and locked-in syndrome (preserved awareness with loss of voluntary motor output) [1]. Critically, large clinical audits have documented that up to 40% of patients diagnosed as VS may retain some degree of covert consciousness, a finding with major ramifications for assessment, care planning, and prognosis [1].
Advancements in Diagnosis and Misdiagnosis Risks
Repeated clinical misdiagnosis of VS versus MCS underscores the importance of standardized assessment tools and emerging neuroimaging. Standardized scales such as the Coma Recovery Scale–Revised (CRS-R) are essential for bedside behavioral assessment [1]. In addition, task-based functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) now enable clinicians to detect “cognitive-motor dissociation”—evidence of command following or cortical response in patients lacking overt behavioral signs. Notably, in an intensive care cohort, up to 25% of patients observed as being in a VS demonstrated fMRI/EEG evidence of volitional brain activity, and these findings correlated with improved recovery at 6 months [1][2]. This suggests that routine integration of advanced neurophysiological paradigms could shift decisions regarding prognosis and care, potentially avoiding premature withdrawal of life-sustaining therapy [2].
Prognosis and Influencing Factors
Prognosis in VS hinges on injury mechanism, patient age, depth of injury, cerebral imaging findings, and—most importantly—the temporal duration of unresponsiveness. Traumatic etiologies generally confer a more favorable prognosis than anoxic injuries, and younger patients are more likely to recover awareness [1]. Nevertheless, the presence of covert consciousness by neuroimaging, even in acute stages, is associated with better functional outcomes at six months, emphasizing the potential for late or unanticipated recovery trajectories [1][2].
Medical, Supportive, and Rehabilitation Management
Management goals for patients in a vegetative state after head injury include the preservation of life, prevention of secondary complications, careful monitoring for neurological improvement, and ongoing reassessment of goals of care. Best practices comprise:
Ethical and Legal Dimensions
Given the risk of diagnostic uncertainty and the evolving landscape of neuroimaging, withdrawal of life-sustaining treatment in VS must be managed through careful, multidisciplinary deliberation, frequent reassessment, and full communication with surrogate decision-makers. Inaccurate diagnosis directly affects access to interventions, family counseling, and impacts patients’ rights and quality of life [1].
Future Directions and Research Priorities
Current research aims to refine early detection of covert consciousness, integrate neurophysiological and neuroimaging markers into standard practice, and clarify the prognostic significance of such findings [1][2]. The development of advanced brain-computer interfaces and novel neural stimulation therapies are under investigation, aiming to restore communication or support further recovery in selected cases.
Conclusion
The vegetative state after head injury embodies a complex, dynamic clinical and ethical challenge. Reliable diagnosis—ideally incorporating behavioral assessment and advanced neuroimaging—is critical to avoid misdiagnosis and inappropriate decisions regarding continuation or withdrawal of care [1][2]. Although sustained recovery remains rare, modern research demonstrates that some patients retain unexpected cognitive reserve and the potential for improved outcome, reinforcing the need for ongoing, vigilant, interdisciplinary management and patient-centered care planning.
MONTI, M.; LAUREYS, Steven; OWEN, A. The vegetative state. BMJ: British Medical Journal, 2010. https://doi.org/10.1136/bmj.c3765.
EDLOW, B., et al. Early detection of consciousness in patients with acute severe traumatic brain injury. Brain, 2017. https://doi.org/10.1093/brain/awx176.
COOPER, D., et al. Decompressive craniectomy in diffuse traumatic brain injury. The New England journal of medicine, 2011. https://doi.org/10.1056/nejmoa1102077.
Role of Occupational therapy in nutritional disorder
Role of Occupational therapy in nutritional disorder
Occupational therapy (OT) plays a pivotal and multifaceted role in the assessment, prevention, and management of nutritional disorders across the lifespan. Unlike traditional nutrition-focused disciplines, occupational therapists address both the functional and occupational impacts of nutritional disorders—such as undernutrition, obesity, and feeding disorders—through a holistic, client-centred lens that incorporates physical, psychosocial, cognitive, environmental, and behavioral factors.
OTs begin with a nuanced assessment, considering not only the physiological underpinnings of nutritional disorder but also the client’s ability to engage in meal preparation, feeding, and the broader routines and habits that shape occupational engagement and well-being. This approach is consistent with a biopsychosocial framework that strives for occupational well-being—defined as satisfying individuals’ needs for agency, accomplishment, and participation in meaningful activities, including those essential to nutrition and eating[1].
For individuals with physical or developmental conditions (e.g., Parkinson’s disease, cerebral palsy, or pediatric feeding disorders), occupational therapists implement interventions to remediate or compensate for limitations in self-feeding and mealtime performance[2][3]. This may involve adaptive equipment (e.g., built-up utensils), task and environment modification, and education in energy conservation strategies, all of which are aimed at restoring autonomy in nutritional self-care[2][3]. In children, OTs employ play-based and sensory integration approaches to improve acceptance of varied food textures and promote independent feeding, with a strong emphasis on engagement and meaningful participation during mealtimes[3][4].
OT practitioners also address nutritional disorders associated with lifestyle and chronic health conditions, such as overweight and obesity. Through client-centred health promotion, they enable individuals to redesign routines to incorporate meal planning, healthy food preparation, and increased participation in physical activities[5]. Evidence suggests that OT interventions for adults with overweight and obesity, although heterogeneous, support short-term weight loss and help individuals reframe the act of eating and physical activity as meaningful, enjoyable occupations[5]. The therapist’s focus is not limited to imparting knowledge but extends to fostering motivation, self-efficacy, and the subjective experience of occupational well-being that sustains behavioral change[1][5].
Furthermore, in the context of functional neurological disorders and mental health conditions, such as eating disorders, OTs implement structured interventions targeting the emotional, cognitive, and routine aspects of eating. These include the use of graded exposure to feared foods, establishing consistent mealtime routines, and addressing distorted occupational identities related to food and body image[6]; these approaches are most effective when delivered as part of multidisciplinary care that may also involve dietitians, psychologists, and speech therapists.
A distinctive strength of OT is its focus on environmental and contextual factors. Occupational therapists advocate for occupational justice by addressing barriers to food access and supporting equitable engagement in meal-related occupations at both individual and community levels[1][7]. For instance, OTs in community or school-based programs may design interventions to help at-risk children or families develop affordable, health-promoting food routines[7]. Collaboration and partnership—involving caregivers, educators, and other professionals—are integral to the OT process and vital for the sustainability of interventions targeting nutritional disorders[7].
In summary, the contribution of occupational therapy to nutritional disorder management extends beyond mere facilitation of feeding or adherence to dietary recommendations. It encompasses the restoration and enhancement of nutritional well-being as a meaningful, chosen, and valued occupation, achieved through individualized, occupation-based assessment and intervention, environmental tailoring, and collaborative, client-empowering strategies[1][3][5][7]. This person-focused, holistic perspective is vital for effective and enduring recovery of health and participation for individuals experiencing nutritional disorders.
DOBLE, S.; SANTHA, J. Occupational well-being: Rethinking occupational therapy outcomes. Canadian Journal of Occupational Therapy, 2008. https://doi.org/10.1177/000841740807500310.
RADDER, Danique L. M., et al. Physical therapy and occupational therapy in parkinson's disease. International Journal of Neuroscience, 2017. https://doi.org/10.1080/00207454.2016.1275617.
HINOJOSA, J. Occupational therapy for children. American Journal of Occupational Therapy, 2011. https://doi.org/10.5014/ajot.41.1.61a.
D'ARRIGO, Rachel G, et al. The engaged child in occupational therapy. Canadian Journal of Occupational Therapy, 2020. https://doi.org/10.1177/0008417420905708.
NIELSEN, S. S.; CHRISTENSEN, J. Occupational therapy for adults with overweight and obesity: Mapping interventions involving occupational therapists. Occupational Therapy International, 2018. https://doi.org/10.1155/2018/7412686.
NICHOLSON, C., et al. Occupational therapy consensus recommendations for functional neurological disorder. Journal of Neurology, Neurosurgery, and Psychiatry, 2020. https://doi.org/10.1136/jnnp-2019-322281.
RENS, Lezahn; JOOSTEN, A. Investigating the experiences in a school-based occupational therapy program to inform community-based paediatric occupational therapy practice. Australian occupational therapy journal, 2014. https://doi.org/10.1111/1440-1630.12093.
tlooto can make mistakes. Check important information against the original sources.